Rethinking Uveal Melanoma Surveillance - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Rethinking Uveal Melanoma Surveillance

Retrospective study questions whether uveal melanoma liver surveillance period should always be extended after five years

  • May 20, 2026

  • 3 min

Share

  • 1

    A study of 1086 uveal melanoma patients suggests that hepatic surveillance may be effective for only five years post-treatment.

  • 2

    29% of patients developed liver metastases, with 93% detected within the first five years of surveillance.

  • 3

    Surveillance protocols currently impose significant imaging burdens, particularly with the use of MRI in resource-constrained systems.

  • 4

    Increasing T stage and tumor location significantly influence metastatic risk, indicating a need for tailored follow-up.

  • 5

    The study advocates for rethinking surveillance protocols to focus on personalized strategies rather than a one-size-fits-all approach.

Original Source(s)

Rethinking Uveal Melanoma Surveillance

  • May 20, 2026

Related Content

Cost-Effectiveness of Electronic Patient-Reported Outcome Measure Interventions in Cancer: Systematic Review and Parameter Extraction for Economic Modeling

Comment on “Life’s essential 8 and specific cancer risk and mortality in men and women: a population-based cohort analysis of 332,417 United Kingdom participants” and the inclusion of sleep in cancer focused guidelines

CAR T Before Surgery Improves Glioblastoma Control in Mice

Study finds that tumor resection creates a more immunosuppressive environment and that earlier CAR T cell treatment prolongs survival

  • September 7, 2026

  • 3 min